在治疗状细胞贫血的慢性输血疗法中添加基尿素可以减少输血负担
Robert Sheppard Nickel1,2,3, Stefanie Margulies1, Karuna Panchapakesan3
1Children's National Hospital, Washington, DC, USA.
Transfusion
|November 24, 2024
概括
在状细胞贫血患者的慢性红细胞输血中添加素尿素是可行的. 这种组合疗法 (HAT) 减少了输血量需求,并且在第二阶段试验中没有显示中风进展.
科学领域:
- 血液学 血液学 血液学
- 儿科神经学 儿科神经学
- 临床药理学 临床药理学
背景情况:
- 慢性红细胞 (RBC) 输血是状细胞贫血 (SCA) 中中风预防的标准.
- 在SCA患者的慢性输血治疗中,每天将基尿素与慢性输血治疗相结合的疗效仍在研究中.
研究的目的:
- 评估在SCA患者的慢性RBC输血治疗中添加剂量升级的基尿素的可行性和影响.
- 评估红细胞输血量要求和安全结果的变化.
主要方法:
- 进行了一项2期临床试验 (NCT03644953),涉及慢性输血SCA患者.
- 参与者除了接受现有的输血方案外,还接受了剂量升级的氨酸尿素.
- 输血量根据输血前的血红蛋白水平在启动氧尿素之前和之后进行调整.
主要成果:
- 在14名参与者中,有9人完成了一年的基尿素和输血 (HAT) 联合治疗.
- 在8名完成者中观察到红细胞输血量显著减少 (中位数为19.4毫升/公斤/年).
- HAT治疗导致Hb S%的增加,平衡着Hb F%的增加和乳酸脱酶的减少,没有脑血管疾病的进展.
结论:
- 在SCA患者的慢性输血治疗中添加基尿素是可行的.
- 组合HAT疗法有效地降低了红细胞输血量需求.
- 在这一群体中,HAT疗法似乎是安全的,并且不会阻碍中风的预防.
相关概念视频
Bone Marrow Sampling and Transplants
284
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
284
Blood Transfusion and Agglutination
10.7K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
10.7K
Blood Transfusion
501
Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
501
Disorders of Erythrocytes
861
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
861
Factors Affecting Erythropoiesis
3.1K
The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
3.1K
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
172
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
172


